Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2667, doi. 10.1038/sj.onc.1202608
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 1999 AND VI 18 AND IP 17
Results: 15
1
2
SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2739, doi. 10.1038/sj.onc.1202613
- By:
- Publication type:
- Article
3
Cell cycle dependent subcellular distribution of Cdc25B subtypes.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2770, doi. 10.1038/sj.onc.1202614
- By:
- Publication type:
- Article
4
Mutator phenotype of BCR – ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase β.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2676, doi. 10.1038/sj.onc.1202619
- By:
- Publication type:
- Article
5
The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2690, doi. 10.1038/sj.onc.1202620
- By:
- Publication type:
- Article
6
HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2703, doi. 10.1038/sj.onc.1202621
- By:
- Publication type:
- Article
7
cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2711, doi. 10.1038/sj.onc.1202623
- By:
- Publication type:
- Article
8
FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2755, doi. 10.1038/sj.onc.1202624
- By:
- Publication type:
- Article
9
Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2728, doi. 10.1038/sj.onc.1202626
- By:
- Publication type:
- Article
10
p19<sup>ARF</sup> prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2718, doi. 10.1038/sj.onc.1202628
- By:
- Publication type:
- Article
11
Induction of apoptosis and G2/M cell cycle arrest by DCC.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2747, doi. 10.1038/sj.onc.1202629
- By:
- Publication type:
- Article
12
The retinoblastoma susceptibility gene product/Sp1 signalling pathway is modulated by Ca<sup>2+</sup>/calmodulin kinases II and IV activity.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2762, doi. 10.1038/sj.onc.1202634
- By:
- Publication type:
- Article
13
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2681, doi. 10.1038/sj.onc.1202631
- By:
- Publication type:
- Article
14
Specific accumulation of Rho-associated kinase at the cleavage furrow during cytokinesis: cleavage furrow-specific phosphorylation of intermediate filaments.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2783, doi. 10.1038/sj.onc.1202633
- By:
- Publication type:
- Article
15
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells.
- Published in:
- Oncogene, 1999, v. 18, n. 17, p. 2777, doi. 10.1038/sj.onc.1202859
- By:
- Publication type:
- Article